StartUs Insights names Toralgen to Top 5 Drug Delivery Startup list

StartUs evaluated 266 emerging Biotech start-ups and highlighted Toralgen as one of 5 promising drug delivery startups.


About Toralgen, Inc.
Toralgen, Inc. is a preclinical stage biopharmaceutical company focused on the development and commercialization of human therapeutics. Its poly-bile nanoparticle platform eliminates many of the inherent challenges of biologics and has the potential to improve outcomes through optimized drug delivery. Toralgen is currently studying treatments for diabetes and autoimmune disorders. For information or to inquire about possible collaborations, visit our website.

Contact: Dave Moore, Toralgen,